MedTrace Logo

Ventricular and Pulmonary Vascular Reserve After the Fontan Operation

NCT03853837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2022-10-06

No results posted yet for this study

Summary

Aim #1: Define and determine the prevalence of pulmonary vascular disease and diastolic dysfunction as assessed by the gold standard of invasive hemodynamic cardiopulmonary exercise testing.

Aim #2: Determine the role of rest-exercise echocardiography for the assessment hemodynamics in Fontan physiology.

Aim #3: Evaluate the clinical impact of pulmonary vascular disease and ventricular diastolic dysfunction.

Conditions

Interventions

DIAGNOSTIC_TEST

rest-exercise echocardiography

an echocardiogram performed during rest and exercise

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Alexander Egbe, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2022-01-04
Completion
2022-07-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853837 on ClinicalTrials.gov